Work Experience 

Todd was the General Manager for the $300 million outsourcing businesses at Cardinal Health (injectable and biotech) and at Cephalon (Cima Labs) where he oversaw the $75 million fast dissolve ODT business.   

Todd was responsible for international marketing for  the $200M global cardiovascular products for Searle including developing pre-commercial launch plans for eplerenone. Todd led the marketing efforts for the GI business (misoprostil) for Searle Canada and the contact lens business for Allergan Canada. 

Todd was head of North American business development at Bayer and Global business development at Watson pharmaceuticals.  While in business development roles he completed over 50 business development transactions from early stage technology deals to late stage collaborations in the branded and generic business including the Allicense biotech deal of the year between Monsanto and Millenium, the ground breaking $1.3 billion authorized generic deal between JNJ and Watson and others.

Education:

Bachelor of Science, University of Prince Edward Island

Masters of Management (MBA), Northwestern University

Areas of Focus:

Commercialization planning

Negotiation

Strategic Marketing

Brand Management

Sales Force design and deployment

Leadership Development

Alliance Management